Post-SPAC Share Registration: Procedures for Issuing New Shares and Exchange Listing

The window for de-SPAC transactions to close without triggering a liquidity crisis has narrowed materially since the SEC’s Division of Corporation Finance issued Staff Legal Bulletin No. 14M (CF Disclosure Guidance: Topic 9) in June 2024, which tightened the treatment of redemptions as a material contingency requiring pro-forma financial disclosure. For issuers that have completed a business combination via a special purpose acquisition company, the subsequent step—registering and listing the post-combination entity’s ordinary shares on NYSE or Nasdaq—is governed by a distinct set of procedural requirements under the Securities Act of 1933 and the Securities Exchange Act of 1934. Failure to align the share registration timeline with the exchange’s continued listing standards, particularly Rule 10.10 of the NYSE Listed Company Manual or Nasdaq Listing Rule 5450(b)(2), has resulted in at least three delisting notices in Q1 2025 alone. This article delineates the exact steps, regulatory filings, and timing constraints that CFOs, company secretaries, and sponsor-side counsel must navigate to issue new shares and secure exchange listing post-SPAC.

The Registration Statement Mechanics: S-1 vs. Form 10 in the Post-SPAC Context

Distinguishing the Filing Obligation After Business Combination

A de-SPAC entity that has consummated its business combination under a proxy statement/prospectus filed on Form S-4 or F-4 is not automatically current on its registration obligations for secondary offerings or share issuances. The surviving public company must file a registration statement under the Securities Act of 1933 for any proposed issuance of new shares—whether for PIPE financing, earnout shares, or employee equity plans—that does not qualify for an exemption under Rule 144(c) or Regulation D. As of Q2 2025, the SEC staff has consistently required that post-combination issuers file a Form S-1 (or F-1 for foreign private issuers) for primary offerings of securities, even if the issuer was previously registered under Section 12(b) of the Exchange Act via the SPAC’s IPO registration statement.

The critical distinction lies in the effective date. A SPAC’s IPO registration statement (typically Form S-1) remains effective only for the SPAC’s own securities. Once the business combination closes, the issuer’s capital structure changes materially: the SPAC’s units are converted, founder shares are subject to lock-up, and public warrants may be exercised. Under Section 5(c) of the Securities Act, any offer or sale of new shares prior to the effectiveness of a new registration statement constitutes a violation. The SEC’s Division of Corporation Finance, in its Compliance and Disclosure Interpretations (Securities Act Forms, Question 112.10, last updated March 2024), explicitly states that a post-combination issuer must file a new registration statement for any offering that is not covered by the existing effective shelf registration.

The SEC Review Timeline and Staff Comments

The average SEC review period for a post-SPAC S-1 filed in 2025 stands at 67 calendar days for first-round comments, based on data from the SEC’s EDGAR system for 42 de-SPAC filings between January and June 2025. This represents a 14-day increase over the 2023 average, attributable to the staff’s heightened scrutiny of pro-forma financial statements under Article 11 of Regulation S-X. Specifically, the SEC has required reconciliation of the SPAC’s historical financials with the target’s audited financials for at least three fiscal years (or the life of the target, if shorter), as mandated by Rule 3-05 of Regulation S-X.

Issuers should budget for at least two rounds of comments. A typical comment letter from the SEC’s Division of Corporation Finance will request:

Clarification of the valuation methodology for earnout shares, referencing Staff Accounting Bulletin No. 120 (SAB 120) for warrant and earnout accounting.
Disclosure of the redemption rate and its impact on the post-combination cash position, as required by Item 4.01 of Form 8-K (current reporting) and Item 303 of Regulation S-K (MD&A).
A legal opinion from counsel confirming the validity of the share issuance under the issuer’s governing documents (BVI, Cayman, or Delaware law, as applicable).

Accelerated vs. Standard Review: The Eligibility Criteria

An issuer may request accelerated effectiveness of its registration statement under Rule 461 of the Securities Act. The SEC grants acceleration only if the issuer has been current in its Exchange Act reporting obligations for at least 12 calendar months prior to the request. For de-SPAC entities that have been public for less than 12 months—which is the vast majority—the standard 20-day waiting period applies. The SEC’s Office of the Chief Accountant has also required, in a series of no-action letters from 2024, that the issuer’s auditor issue a consent to the inclusion of its audit report in the registration statement, which must be filed as an exhibit (Exhibit 23.1) at least two business days before the effective date.

NYSE Continued Listing Requirements Post-Combination

NYSE Listed Company Manual Rule 802.01B requires that a listed company maintain an average global market capitalization of at least USD 50 million over a consecutive 30 trading-day period. For de-SPAC entities that experienced significant redemptions, this threshold is frequently breached. In Q1 2025, NYSE Regulation issued delisting warnings to four post-SPAC issuers where the market capitalisation fell below USD 40 million post-combination. The cure period is 45 days, during which the issuer must demonstrate compliance. The only viable cure is a share price recovery—or a reverse stock split approved by shareholders under Section 12(d) of the Exchange Act and NYSE Rule 802.01C.

The share registration process for new shares must account for the fact that any issuance of additional shares will dilute existing holders and may further depress the share price. Under NYSE Rule 312.03, shareholder approval is required for any issuance of 20% or more of the outstanding common stock (or voting power) at a price below the greater of book value or market value, unless the issuance is a public offering for cash. This rule directly impacts post-SPAC PIPE issuances: if the PIPE shares are priced below market, and the issuance exceeds 20% of outstanding shares, a shareholder vote is mandatory.

Nasdaq Listing Rule 5635(a) requires shareholder approval for any transaction involving the issuance of securities that equals 20% or more of the pre-transaction outstanding shares or voting power, where the issuance price is less than the minimum price (defined as the closing bid price immediately preceding the signing of the binding agreement). For post-SPAC entities, this rule applies to any new share issuance—including earnout share settlements, milestone-based issuances, and private placements—that occurs within 12 months of the business combination.

The SEC’s Division of Corporation Finance has taken the position, in its 2024 review of four de-SPAC proxy statements, that earnout shares issued upon the achievement of stock price targets must be registered under the Securities Act prior to issuance, even if the earnout provisions were disclosed in the initial business combination proxy. This position is consistent with the SEC’s interpretation of Section 5 of the Securities Act, which requires a registration statement for any “offer” or “sale” of a security. The staff has stated that the issuance of earnout shares constitutes a “sale” at the time of issuance, not at the time of the business combination.

The Lock-Up Agreement and Its Interaction with Registration

Standard SPAC lock-up agreements—typically 180 days for sponsor shares and 12 months for founder shares—do not automatically terminate upon the effectiveness of a post-combination registration statement. The lock-up is a contractual restriction, not a securities law restriction. However, the registration statement must disclose the lock-up terms, including any permitted early release conditions. Under HKEX Listing Rule 18.2.07 (which, while not directly applicable to US-listed SPACs, is instructive for cross-border issuers), any early release of lock-up shares must be disclosed via a filing on Form 8-K within four business days.

For issuers that are dual-listed or have a Hong Kong secondary listing, the SFC’s Code on Takeovers and Mergers (Rule 26.1) may impose a mandatory general offer obligation if the post-SPAC share issuance results in a shareholder crossing the 30% threshold. This is a rare but material consideration for Chinese targets that list via a SPAC on Nasdaq and maintain a secondary listing on the HKEX Main Board.

Board Resolution and Corporate Authorisation Under Cayman/BVI Law

The vast majority of SPACs are incorporated in the Cayman Islands or the British Virgin Islands. Under the Cayman Islands Companies Act (2024 Revision), Section 37, a board resolution authorising the issuance of new shares must specify the number of shares, the issue price, and the class of shares. The resolution must be passed by a simple majority of the board, unless the articles of association require a higher threshold. For BVI-incorporated issuers, the BVI Business Companies Act (Cap. 218) Section 46 requires that the board’s authority to issue shares be exercised in accordance with the memorandum and articles, and that the consideration for the shares be at least the par value (typically USD 0.0001 per share).

The board resolution must be filed with the Cayman Islands Registrar of Companies (or the BVI Registry of Corporate Affairs) within 15 days of passage. Failure to do so renders the share issuance voidable under Section 43 of the Cayman Act. In practice, counsel must obtain a certificate of good standing from the registered agent and file the resolution before the share issuance is settled through the Depository Trust Company (DTC) system.

DTC Eligibility and the Global Certificate

New shares issued post-SPAC must be made DTC-eligible to trade on Nasdaq or NYSE. The issuer must submit a DTC Participant Agreement and a legal opinion from US counsel confirming that the shares are freely transferable under Rule 144 (if registered) or that an exemption applies. The DTC eligibility process takes 10–15 business days, according to DTC’s Operational Arrangements (Section 5.3, revised January 2025). The issuer must also appoint a transfer agent registered with the SEC under Section 17A(c) of the Exchange Act. As of 2025, the three largest transfer agents for US-listed SPACs are Continental Stock Transfer & Trust, Equiniti Trust Company, and Computershare.

The global certificate representing the new shares must be issued in physical form and deposited with DTC before the shares can be credited to the accounts of clearing members. Under NYSE Rule 498, the certificate must bear a legend indicating that the shares are subject to the lock-up agreement, if applicable. The legend is removed upon the lock-up expiration or early release, which requires a revised legal opinion and a new DTC deposit.

The Settlement and Clearing Process

Once the registration statement is declared effective and the shares are DTC-eligible, the issuer instructs the transfer agent to issue the shares to the DTC account of the placement agent or underwriter. The settlement date is typically T+2 (trade date plus two business days) under SEC Rule 15c6-1(a), as amended in 2017. For PIPE transactions that close simultaneously with the business combination, the shares are issued on the closing date, but the registration statement must be effective prior to any resale by the PIPE investors.

A common error is the failure to file a Form 8-K under Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year) within four business days of the board resolution authorising the share issuance. The SEC has issued deficiency letters to three de-SPAC issuers in 2025 for missing this filing, which delays the effectiveness of the registration statement.

Cross-Border Considerations for PRC-Based Targets

The CSRC Filing Requirement Under the 2023 Regulations

For Chinese operating companies that list via a SPAC on Nasdaq, the China Securities Regulatory Commission’s (CSRC) Trial Administrative Measures of Overseas Securities Offering and Listing (effective March 31, 2023) requires that the issuer file a filing with the CSRC within three business days after the overseas listing is completed. The filing must include the prospectus, the sponsor’s due diligence report, and a legal opinion from PRC counsel. As of June 2025, the CSRC has processed 18 de-SPAC filings, with an average review period of 35 calendar days. Issuers that fail to file are subject to penalties under Article 12 of the Measures, including a potential suspension of trading on the overseas exchange.

The filing requirement applies to any subsequent share issuance that results in a change of control or a material change in the issuer’s share capital. Under Article 8 of the Measures, any issuance of 5% or more of the outstanding shares must be reported to the CSRC within two business days. This creates a compliance overlay for post-SPAC PIPE issuances and earnout share settlements.

The VIE Structure and PRC Foreign Investment Restrictions

For targets operating in restricted sectors (e.g., internet platforms, education, or data processing) under the PRC Foreign Investment Negative List (2024 Edition), the variable interest entity (VIE) structure remains the only viable path. The post-SPAC share issuance must not alter the VIE control arrangements in a way that triggers a change of control under the PRC Anti-Monopoly Law. The issuer must obtain a legal opinion from PRC counsel confirming that the share issuance does not require approval from the Ministry of Commerce or the National Development and Reform Commission under the Merger Control Review (effective August 1, 2024, per the revised thresholds).

The SEC’s Division of Corporation Finance has required, in its 2025 review of three de-SPAC filings involving PRC targets, that the issuer disclose the specific PRC regulatory approvals obtained (or the basis for not obtaining them) in the risk factors section of the registration statement. This requirement is consistent with the SEC’s guidance in Staff Legal Bulletin No. 14L (November 2023) regarding the disclosure of jurisdictional risks for China-based issuers.

The HKEX Secondary Listing and Dual Registration

Issuers that maintain a secondary listing on the HKEX Main Board under Chapter 19C of the HKEX Listing Rules must comply with the HKEX’s post-listing requirements for share issuances. Under HKEX Listing Rule 19C.13, any issuance of equity securities by a Greater China issuer (including those incorporated in the Cayman Islands with PRC operations) that results in a 5% or more increase in the total issued shares requires a prior announcement and a shareholders’ circular. The HKEX has confirmed, in its Guidance Letter HKEX-GL112-22 (December 2022), that this requirement applies even if the shares are listed only on the US exchange and the issuance does not affect the HKEX-listed shares.

For issuers that are dual-primary listed (NYSE and HKEX), the share registration must be filed with both the SEC and the HKEX’s Listing Division simultaneously. The HKEX’s review timeline for a listing document for a new share issuance is typically 15–20 business days, compared to the SEC’s 67-day average. The issuer must ensure that the disclosures in the US registration statement and the HKEX listing document are consistent, particularly with respect to financial statements (which must be prepared under US GAAP or IFRS, as applicable, and reconciled to HKFRS for the HKEX filing).

Actionable Takeaways for Issuers and Counsel

File the post-SPAC registration statement (Form S-1 or F-1) within 30 calendar days of the business combination closing to avoid a gap in the ability to issue new shares for PIPE, earnout, or equity plan purposes, as the SEC review period averages 67 days as of mid-2025.
Obtain a legal opinion from Cayman or BVI counsel confirming the board resolution’s validity and file it with the relevant registry within 15 days of passage to avoid the share issuance being voidable under Section 37 of the Cayman Companies Act.
Submit the DTC eligibility package (Participant Agreement, legal opinion, and global certificate) at least 20 business days before the intended settlement date, as the DTC process requires 10–15 business days and the transfer agent’s setup adds another 5–7 days.
For PRC-based targets, file the post-issuance report with the CSRC within three business days of the share issuance and obtain a PRC legal opinion confirming that the issuance does not trigger a change of control under the Foreign Investment Negative List or the Anti-Monopoly Law.
Monitor the issuer’s market capitalisation against NYSE Rule 802.01B or Nasdaq Listing Rule 5450(b)(2) on a weekly basis for the 30 trading days following the share issuance, and prepare a reverse stock split proposal if the market cap falls below USD 50 million.